How long does it take to stop taking pirfenidone (Isri) and advice on how to stop taking it safely?

Pirfenidone (Pirfenidone) is an anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). Its mechanism of action is to slow down the progression of pulmonary fibrosis rather than cure the disease. Since IPF is a chronic progressive disease and there is currently no cure, pirfenidone usually requires long-term or even lifelong use. Under normal circumstances, doctors will not easily advise patients to stop taking medications on their own, unless serious adverse reactions or clear medical indications occur, otherwise stopping the medication may lead to rapid progression of the disease.

In actual clinical practice, whether patients can discontinue medication mainly depends on disease control and tolerance. If a patient experiences severe liver damage, allergic reactions, or persistent gastrointestinal adverse reactions while taking the drug, the doctor will evaluate whether the dose needs to be reduced or discontinued. However, for most patients who are able to tolerate the drug, continued long-term use of pirfenidone is recommended because once treatment is discontinued, fibrosis may develop more rapidly and respiratory function may decline more quickly.

For some patients whose condition is stable and who have been taking pirfenidone for a long time, if they consider stopping the drug, they must be gradually evaluated under the close monitoring and advice of their doctors. Doctors usually use pulmonary function tests (such as FVC, DLCO), imaging review (CT) and changes in clinical symptoms to determine whether it is appropriate to reduce the dose or discontinue the drug, rather than relying solely on the patient's self-perception. Even if the medication is stopped, close follow-up is required in the short term to detect changes in the condition in a timely manner.

Therefore, the decision to discontinue pirfenidone must be individualized and cannot be stopped blindly. The safe approach is to strictly follow medical advice and conduct necessary examinations and evaluations under the guidance of professional doctors. If patients stop taking the drug on their own, it may cause irreversible lung function damage and increase the risk of acute exacerbation. Overall, pirfenidone should be considered a"long-term management drug" and discontinuation requires careful weighing of the risks and benefits and must be done under a physician's supervision.

Reference materials:https://www.drugs.com/